Article ID Journal Published Year Pages File Type
5532230 European Journal of Cell Biology 2017 12 Pages PDF
Abstract

•TGF-β2 induces up to an intermediate mesenchymal phenotype in HMEC-1.•MMP-2 is responsible for most proteolytic activity in HMEC-1 exposed to TGF-β2.•MMP-2 is localized within invadosome.•HMEC-1 present mixed amoeboid/mesenchymal migratory mode during EndMT.

The contribution of endothelial cells to scar and fibrotic tissue formation is undisputedly connected to their ability to undergo the endothelial-to-mesenchymal transition (EndMT) towards fibroblast phenotype-resembling cells. The migration model of fibroblasts and fibroblast-resembling cells is still not fully understood. It may be either a Rho/ROCK-independent, an integrin- and MMP-correlated ECM degradation-dependent, a mesenchymal model or Rho/ROCK-dependent, integrin adhesion- and MMP activity-independent, an amoeboid model. Here, we hypothesized that microvascular endothelial cells (HMEC-1) undergoing EndMT adopt an intermediate state of drifting migration model between the mesenchymal and amoeboid protrusive types in the early stages of fibrosis. We characterized the response of HMEC-1 to TGF-β2, a well-known mediator of EndMT within the microvasculature. We observed that TGF-β2 induces up to an intermediate mesenchymal phenotype in HMEC-1. In parallel, MMP-2 is upregulated and is responsible for most proteolytic activity. Interestingly, the migration of HMEC-1 undergoing EndMT is dependent on both ECM degradation and invadosome formation associated with MMP-2 proteolytic activity and Rho/ROCK cytoskeleton contraction. In conclusion, the transition from mesenchymal towards amoeboid movement highlights a molecular plasticity mechanism in endothelial cell migration in skin fibrosis.

Graphical abstractDownload high-res image (141KB)Download full-size image

Related Topics
Life Sciences Agricultural and Biological Sciences Plant Science
Authors
, , , ,